State of New Jersey Common Pension Fund D Acquires New Holdings in 1Life Healthcare, Inc. (NASDAQ:ONEM)

State of New Jersey Common Pension Fund D acquired a new stake in 1Life Healthcare, Inc. (NASDAQ:ONEM – Get Rating) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 139,578 shares of the company’s stock, valued at approximately $2,394,000. State of New Jersey Common Pension Fund D owned 0.07% of 1Life Healthcare at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC increased its stake in 1Life Healthcare by 3.1% during the second quarter. SG Americas Securities LLC now owns 23,304 shares of the company’s stock worth $183,000 after purchasing an additional 702 shares during the period. CWM LLC increased its stake in 1Life Healthcare by 102.7% during the second quarter. CWM LLC now owns 3,572 shares of the company’s stock worth $28,000 after purchasing an additional 1,810 shares during the period. US Bancorp DE increased its stake in 1Life Healthcare by 88.8% during the first quarter. US Bancorp DE now owns 4,492 shares of the company’s stock worth $50,000 after purchasing an additional 2,113 shares during the period. Van ECK Associates Corp purchased a new stake in 1Life Healthcare during the third quarter worth about $38,000. Finally, Rhumbline Advisers increased its stake in 1Life Healthcare by 2.8% during the first quarter. Rhumbline Advisers now owns 127,469 shares of the company’s stock worth $1,412,000 after purchasing an additional 3,448 shares during the period. 78.20% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Credit Suisse Group lowered shares of 1Life Healthcare from an “outperform” rating to a “neutral” rating and set a $18.00 price target on the stock. in a research note on Thursday, October 27th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $16.50.

Insider Activity at 1Life Healthcare

In related news, General Counsel Lisa A. Mango sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 19th. The stock was sold at an average price of $17.06, for a total value of $42,650.00. Following the completion of the transaction, the general counsel now directly owns 88,385 shares of the company’s stock, valued at $1,507,848.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, General Counsel Lisa A. Mango sold 2,500 shares of the stock in a transaction that occurred on Wednesday, October 19th. The stock was sold at an average price of $17.06, for a total value of $42,650.00. Following the completion of the sale, the general counsel now directly owns 88,385 shares of the company’s stock, valued at $1,507,848.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Bjorn B. Thaler sold 6,116 shares of the stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $16.72, for a total value of $102,259.52. Following the completion of the sale, the chief financial officer now directly owns 13,718 shares of the company’s stock, valued at $229,364.96. The disclosure for this sale can be found here. Insiders sold 324,739 shares of company stock valued at $5,541,232 over the last three months. 4.40% of the stock is owned by corporate insiders.

1Life Healthcare Price Performance

Shares of ONEM opened at $16.42 on Tuesday. The stock has a 50 day moving average price of $16.73 and a 200 day moving average price of $16.27. The company has a quick ratio of 2.06, a current ratio of 2.09 and a debt-to-equity ratio of 0.20. 1Life Healthcare, Inc. has a 52-week low of $5.94 and a 52-week high of $17.55.

1Life Healthcare (NASDAQ:ONEM – Get Rating) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.10). The business had revenue of $261.37 million during the quarter, compared to analyst estimates of $273.51 million. 1Life Healthcare had a negative net margin of 39.15% and a negative return on equity of 23.82%. The business’s revenue for the quarter was up 72.7% compared to the same quarter last year. During the same period last year, the company earned ($0.51) earnings per share. Equities analysts predict that 1Life Healthcare, Inc. will post -2.05 earnings per share for the current fiscal year.

About 1Life Healthcare

(Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.